Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehmet Poyrazer has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Rıdvan Erten

    Division of Geriatrics, Department of Internal Medicine, Faculty of Medicine, Kocaeli University

    2 shared publications
  • Hüseyin Yağcı

    Division of Endocrinology and Metabolism, University of Health Sciences Ankara Training and Research Hospital

    1 shared publication

Latest Publications

  • Open Access

    How well do frozen foundation models transfer? A calibration-focused benchmark for diabetic retinopathy grading

    by Mehmet Poyrazer, Hüseyin Yağcı, Rıdvan Erten

    Background: Pretrained foundation models are increasingly adopted for diabetic retinopathy (DR) screening, yet it remains unclear how much of their performance derives from the learned representations versus the adaptation procedure. Most benchmarks report discrimination metrics alone, neglecting probability calibration. Methods: We compared the frozen representations of three pretrained encoders: MedSigLIP (medical vision–language; ViT-B/16, 448 × 448), RETFound (retinal self-supervised; ViT-L/16, 224 × 224), and EfficientNet-B0 (ImageNet-supervised; 224 × 224). All encoder weights were frozen; only an identical lightweight multilayer perceptron head was trained. Models were developed on APTOS 2019 (3,662 fundus images; five-fold cross-validation) and externally validated on MESSIDOR-2 (1,744 images). Binary referable DR detection and five-class severity grading were evaluated. AUC, expected calibration error (ECE), and Brier score served as co-primary endpoints. External-set tests used patient-level cluster-robust bootstrap to account for bilateral correlation. Results: On the development set, all three encoders achieved near-identical binary AUC (0.980–0.985). MedSigLIP showed superior calibration, with a lower Brier score than RETFound (0.044 vs. 0.049; p = 0.030) and EfficientNet-B0 (0.044 vs. 0.052; p = 0.006). External validation on MESSIDOR-2 revealed divergence: MedSigLIP maintained an AUC of 0.915 (drop 0.070), whereas RETFound fell to 0.697 (drop 0.286) and EfficientNet-B0 to 0.745 (drop 0.236). Retina-specific RETFound performed below the ImageNet baseline (ΔAUC = −0.051; p = 0.016, cluster-robust bootstrap). For five-class grading, MedSigLIP achieved an external macro-F1 of 0.450 versus 0.247 (RETFound) and 0.291 (EfficientNet-B0). Temperature scaling reduced development ECE to 0.014–0.022 but proved ineffective under domain shift (external ECE 0.086–0.149). All encoders exhibited catastrophic failure on mild DR (grade 1) externally, with RETFound and EfficientNet-B0 achieving F1 = 0.000 and MedSigLIP only 0.153. Conclusion: Under frozen transfer, the MedSigLIP encoder package produced more generalisable and better calibrated representations than both retinal self-supervised (RETFound) and ImageNet-supervised (EfficientNet-B0) encoders. Domain-specific pretraining did not guarantee domain-general frozen representations. These findings demonstrate that development-set discrimination alone is insufficient for encoder evaluation and that calibration metrics—particularly the Brier score—should be reported as standard practice.


  • Open Access

    An early evaluation of MedSigLIP in thyroid cytology: a comparative frozen-encoder benchmark against ImageNet-pretrained encoders

    by Mehmet Poyrazer, Rıdvan Erten

    Background: Fine-needle aspiration biopsy (FNAB) cytology is central to thyroid nodule evaluation, yet reliable differentiation across Bethesda categories remains challenging, particularly for the indeterminate Bethesda V (Suspicious for Malignancy) class. While transfer learning with ImageNet-pretrained models is a standard approach, it remains unclear whether emerging domain-specific medical foundation models offer superior performance compared to general purpose baselines in this specialized domain. Methods: We benchmarked four frozen visual encoders—ResNet50, EfficientNet-B0, ViT-Base (ImageNet pretrained), and MedSigLIP (medical image–text pretrained)—on the ThyroidEffi 1.0 dataset (N = 1,804), comprising Bethesda II (Benign), Bethesda V (Suspicious), and Bethesda VI (Malignant) cases. A unified evaluation protocol was employed using five-fold stratified cross-validation with a lightweight multilayer perceptron head. Performance was assessed using macro-F1, balanced accuracy, Expected Calibration Error (ECE), and McNemar’s test for statistical significance. Results: EfficientNet achieved the highest macro-F1 (0.845 ± 0.021), followed closely by MedSigLIP (0.836 ± 0.019), ResNet50 (0.829 ± 0.015), and ViT (0.817 ± 0.020). Pairwise statistical testing revealed that while EfficientNet significantly outperformed ViT (p < 0.05), the difference between EfficientNet and MedSigLIP was not statistically significant after multiple comparison correction. Notably, MedSigLIP demonstrated superior reliability attributes, achieving the highest recall for the challenging Suspicious class (0.808) and the best model calibration score (ECE = 0.025) compared to the general-purpose encoders (ECE: 0.044–0.082). Conclusions: While domain-specific medical pretraining (MedSigLIP) did not yield a statistically significant advantage in aggregate classification accuracy compared to the best ImageNet-based model (EfficientNet), it provided superior calibration and sensitivity for borderline cases. These findings suggest that in thyroid cytology clinical workflow support, encoder selection should be guided by a joint view of discrimination and safety—particularly calibration and Bethesda V sensitivity—rather than aggregate accuracy alone, enabling threshold-based triage and selective expert review. In particular, well-calibrated models such as MedSigLIP suggest a potential benefit in reducing overconfident misclassification in borderline Bethesda V cases, pending prospective validation in real-world triage workflows.